Georgia CTSA Newsletter
|
Trouble viewing this email? View on the web.
| |
|  | 
Georgia CTSA
Weekly eRoundup
May 25, 2018
|
| |
| |  | | The University of Georgia College of Veterinary Medicine has been accepted as a member of the Clinical and Translational Science Award One Health Alliance (COHA). UGA joined a Clinical and Translational Science Award (CTSA) in September (read the news release), along with Emory University, Morehouse School of Medicine, and the Georgia Institute of Technology, the four academic partner institutions makeup the Georgia Clinical & Translational ... | | | | Read More | | |
| |
| | | | The foundation is seeking project applications to improve health-care access and outcomes for underserved populations, particularly addressing chronic conditions and noncommunicable diseases. Health organizations and other related groups may apply for one-year grants worth $50,000 to $100,000; up to 10 grants will be awarded. | | | | Read More | | |
| |
| | | | This fine-year initiative is to improve health, prevent chronic diseases, and reduce health disparities among racial and ethnic populations with the highest risk, or burden, of chronic disease, specifically for African Americans, Hispanic Americans, Asian Americans, Native Hawaiian/Other Pacific Islanders, American Indians, and Alaska Natives. | | | | Read More | | |
| |
| | | | The purpose of the grant is to support high quality conferences that are relevant to the public health and to the scientific mission of the participating Institutes and Centers. | | | | Read More | | |
| |
| | | | Supports exceptionally creative early career scientists proposing innovative and high-impact projects. The NIH definition of an Early Stage Investigator now includes clinical training. RFA-RM-18-008 | | | | Read More | | |
| |
| | | | Deprescribing, the cessation of long-term therapy under clinician supervision, is a fundamental technique of geriatric practice and palliative medicine to address inappropriate medication use and/or polypharmacy common among older adults with multimorbidity. | | | | Read More | | |
| |
| | | | Supports individuals or teams proposing projects that are inherently risky and untested but have the potential to create or overturn fundamental paradigms. | | | | Read More | | |
| |
| | | | The purpose of this program is to recruit and retain outstanding, postdoctoral-level health professionals who have demonstrated potential and interest in pursuing careers as clinician-investigators. | | | | Read More | | |
| |
| | | | This FOA supports highly promising healthcare and academic professionals, in the early years of one's first professional appointment, to explore innovative questions or pilot studies that will provide preliminary data and training necessary to assure the applicant's future success as a research scientist in the field of cardiovascular and stroke research. | | | | Read More | | |
| |
| | | | Authorship-Read this, but don't tell anybody | | | | Read More | | |
| |
| | | | FasterCures continues the important work of evaluating how the biomedical research and development system measures and utilizes the outcomes that matter most to patients. | | | | Read More | | |
| |
| | | | The purpose of the award is to facilitate and accelerate the capital-intensive steps that are required to transition SBIR/STTR Phase II projects to the commercialization stage by promoting partnerships between SBIR/STTR Phase II awardees and third-party investors and/or strategic partners. Applicants must submit a Commercialization Plan, which should include details on any independent third-party funding that has already been secured or is anticipated during the Phase IIB Bridge Award project period. | | | | Read More | | |
| |
| | | | The purpose of the award is to provide support to Phase II SBIR or STTR awardees that are developing NHLBI mission-related products that address a rare disease or young pediatric populations. The goal of this FOA is for these products to be further validated so that development can continue with private funding after NHLBI support ends. Applicants must submit a Commercialization Plan that includes details on any independent third-party funding that has already been secured or is anticipated during the project period. | | | | Read More | | |
| |
| | | | This session is an opportunity for community members to provide meaningful input on the NIH-wide Minority Health and Health Disparities Strategic Plan. Held at Morehouse School of Medicine from 8:30 a.m.-12:30 p.m. Provide input on the national agenda and priorities for minority health and health disparities research, strategic partnerships, initiatives, and dissemination. Opening remarks by Dr. Eliseo J. Perez-Stable, director of the National Institute on Minority Health and Health Disparities. | | | | Read More | | |
| |
| | | | The 5K is a family friendly event that will raise money for innovative cancer research at Winship Cancer Institute of Emory University, starting at 8:30 a.m. on Emory's Quad. | | | | Read More | | |
| |
| | | | NCATS will jointly host a webinar about NIH's small business funding and applicant support programs. Sponsored in part by NCATS, the National Cancer Institute's (NCI) Small Business Innovation Research (SBIR) Development Center and the Women's Business Development Center (WBDC), the webinar will focus on NIH's SBIR and Small Business Technology Transfer funding programs, NCI and NCATS resources, and free applicant assistance programs. | | | | Read More | | |
| |
| | | | Hear final pitches from thirteen creative UGA I-Corps Accelerator teams participating in the May 2018 cohort. These teams demonstrate the spectrum of UGA innovation and the people who drive it forward. Stop by from 4:00-6:00 p.m. for some refreshments and great ideas! | | | | Read More | | |
| |
| | | | This webinar will introduce Figshare, a free, online digital repository where researchers can preserve and share their research outputs, including figures, datasets, images, and videos. | | | | Read More | | |
| |
| | | | FasterCures will host a webinar to discuss the FDA's Patient-Focused Drug Development (PFDD) initiative. During this webinar, panelists will share their experiences working with patient communities to plan for these often-intense PFDD listening sessions, as well as what they've learned from them and how they are applying this information. | | | | Read More | | |
| |
| | | | This webinar will include an overview of the resources available on the Trial Innovation Network Toolkit. From study design to participant recruitment and engagement, the Trial Innovation Network offers many self-service tools and resources to help investigators throughout the entire life cycle of their projects. | | | | Read More | | |
| |
| |  | | Registration deadline today, February 15.
Michael G. Kurilla, MD, PhD, director, Division of Clinical Innovation, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health will serve as keynote speaker. Georgia CTSA brings together researchers from across the state to present the best new clinical and translational research and build collaborative partnerships. The conference will be held at the beautiful Callaway ... | | | | Read More | | |
| |
| | | | NCATS seeks scientific investigators from the NIH intramural and extramural communities, as well as those from the biotech and pharmaceutical industry, to collaborate on projects through its Stem Cell Translation Laboratory (SCTL). The next proposal deadline is July 1, 2018. The SCTL is a state-of-the-art research facility designed to address the scientific and technological challenges in the induced pluripotent stem cell (iPSC) field. | | | | Read More | | |
| |
| For more information on Georgia Clinical & Translational Science Alliance (Georgia CTSA), please visit
www.GeorgiaCTSA.org. Do you have news, seminars, or events of interest to clinical and translational researchers? Send them to
GeorgiaCTSA@emory.edu by noon on Thursday. To suggest subscribers or unsubscribe to the listserv please email
GeorgiaCTSA@emory.edu.
Please include the following citation in any publications resulting from direct or indirect Georgia CTSA support, "Supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under Award Number UL1TR002378. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health." KL2 Scholars should also list KL2TR002381 and TL1 Trainees should also list TL1TR002382. |
| |
|
